FOXO4-DRI

A "senolytic" peptide that targets and eliminates senescent (zombie) cells, aiding in tissue rejuvenation and longevity.

FOXO4-DRI

FOXO4-DRI

A "senolytic" peptide that targets and eliminates senescent (zombie) cells, aiding in tissue rejuvenation and longevity.

  • Starting at $549
Order FOXO4-DRI

What Is FOXO4-DRI?

FOXO4-DRI is a senolytic peptide designed to selectively target and eliminate senescent (“zombie”) cells—cells that have stopped dividing but release inflammatory factors that accelerate aging and tissue dysfunction. By clearing these damaged cells, FOXO4-DRI supports tissue rejuvenation, improves cellular function, and promotes longevity.

  • Targets and removes senescent cells
  • Reduces chronic inflammation associated with aging
  • Supports tissue regeneration and overall cellular health

Who Can Benefit from FOXO4-DRI?

FOXO4-DRI is ideal for individuals who are focused on anti-aging and longevity strategies and want to reduce cellular senescence and improve tissue health.

  • Clears senescent cells to improve tissue function
  • Reduces inflammation and cellular stress
  • Supports rejuvenation of organs, muscles, and connective tissue

OUR CLIENTS LOVE US - SEE WHAT THEY'RE SAYING

Frequently Asked Questions –
Your Concierge Healthcare, Simplified

It is typically administered via subcutaneous injection under clinical supervision.

Cellular and tissue benefits may appear weeks to months after administration, depending on overall health and protocol.

Early research shows promise, but long-term human studies are limited. Clinical guidance is recommended.

Yes, it can be integrated with anti-aging or regenerative peptides like Epithalon, DSIP, or BPC-157 for broader longevity and cellular repair protocols.